At meeting held on 21 May 2024
The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite scheme of arrangement u/s 230 to 232 read with section 66 and other applicable provisions of the Companies Act, 2013, amongst Eris Lifesciences and Eris Oaknet Healthcare and their respective Shareholders and Creditors.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
